GW 876008X(786701-13-1)
- Name: GW 876008X
- Synonyms:
- Molecular Formula:
- Molecular Weight:404.472
- CAS Registry Number:786701-13-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.786701-13-1 GW 876008X
Assay:99% Transportation:By sea Application:Pharmaceutical industry
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)] CAS No.786701-13-1 GW 876008X
Assay:99% Application:api
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.786701-13-1 GW 876008X
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:GW 876008X
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.786701-13-1 GW 876008X
Assay:99% Transportation:By sea Application:Pharmaceutical industry
Min. Order:0
Supplier:Hubei Jiutian Bio-medical Technology Co., Ltd [
China (Mainland)] CAS No.786701-13-1 GW 876008X;786701-13-1
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.786701-13-1 Emicerfont
Assay:98% Appearance:Powder Package:inquiry Storage:-20鈩?Freezer Transportation:inquiry Application:Emicerfont is a Corticotropin releasing factor receptor 1 antagonist. It can block the CRF1 receptor and so reduce ACTH release. It has been investigated for the treatment of irritable bowel syndr...
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 732983-37-8/BAY 61-3606
- 865538-96-1/(S)-3-benzyldihydrofuran-2,5-dione
- 934763-10-7/GSK-982
- 952486-41-8/PSN-119-2
- 915397-18-1/Pyrido[3,4-b]pyrazin-2(1H)-one, 1-(2-ethoxyethyl)-7-(6-methoxy-3-pyridinyl)-3-[[2-(4-morpholinyl)ethyl]amino]-
- 915396-72-4/Pyrido[3,4-b]pyrazin-2(1H)-one, 7-(6-methoxy-3-pyridinyl)-3-[[2-(4-morpholinyl)ethyl]amino]-1-(2-propoxyethyl)-
- 1093069-95-4/2-Thiophenesulfonamide, N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[4-(4-ethyl-1-piperazinyl)-1,3-dihydro-1-oxo-2H-isoindol-2-yl]butyl]-
- 1093069-32-9/1H-Imidazole-4-sulfonamide, N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[4-(4-ethyl-1-piperazinyl)-1,3-dihydro-1-oxo-2H-isoindol-2-yl]butyl]-1,2-dimethyl-
- 1067186-56-4/PSI-421
- 1216744-19-2/1,1-Dimethylethyl-N-[(4-chlorophenyl)methyl]-N-[(5-nitro-2-thienyl)methyl])glycinate
- 163630-80-6/Siramesine
- 1033-69-8/Piperazine, 1-(2-phenylethyl)-4-(2-pyridinyl)-
- 1194372-99-0/Piperidine, 1-cyclohexyl-4-[3-(1,2,3,4-tetrahydro-5-methoxy-1-naphthalenyl)propyl]-
- 1188407-45-5/2-Pyrazinecarbonitrile, 4-[(1S)-1-cyclopropyl-2-methoxyethyl]-6-[[6-(difluoromethoxy)-2,5-dimethyl-3-pyridinyl]amino]-4,5-dihydro-5-oxo-
- 1116571-01-7/1-Piperazinecarboximidamide, N'-(3-bromophenyl)-N-cyano-2-methyl-4-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (2S)-
- 1082743-32-5/4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1-cyclopentyl-1,5-dihydro-6-[(3S,4S)-4-methyl-1-(6-quinoxalinylmethyl)-3-pyrrolidinyl]-
- 1197300-24-5/4-Isoxazolecarboxamide, 3-(2-chlorophenyl)-N-(4-chlorophenyl)-N,5-dimethyl-
- 869769-98-2/INCB9471
- 308824-37-5/SC-77964
- 786701-13-1/GW 876008X
- 1262406-02-9/2-Benzothiazolamine, N-propyl-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 1262406-08-5/6H-Pyrazolo[3,4-b]pyridin-6-one, 1,7-dihydro-4-(trifluoromethyl)-3-[3-(trifluoromethyl)phenyl]-
- 1245527-15-4/1H-Pyrrolo[2,3-c]pyridine-2-ethanol, α-[2-[2-methoxy-5-(5-pyrimidinyl)phenyl]-2-methylpropyl]-α-(trifluoromethyl)-, (αR)-
- 1245526-82-2/Glucocorticoid receptor agonist
- 1146395-46-1/Benzeneacetamide, 4-(3-methyl-2-pyrazinyl)-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]-
- 869725-27-9/Methanone, (4,6-dimethyl-5-pyrimidinyl)[4-[(3S)-4-[(1R,2R)-2-ethoxy-2,3-dihydro-5-(trifluoromethyl)-1H-inden-1-yl]-3-methyl-1-piperazinyl]-4-methyl-1-piperidinyl]-, hydrochloride (1:2)
- 1021298-13-4/Methanone, [4-methyl-3-(1-pyrrolidinylsulfonyl)phenyl](octahydro-2(1H)-isoquinolinyl)-
- 887289-02-3/Benzamide, N-[2-(cyclopropylmethyl)-5-(1,1-dimethylethyl)-1,2-dihydro-1-methyl-3H-pyrazol-3-ylidene]-2-fluoro-3-(trifluoromethyl)-
- 452296-83-2/BMS 043
- 668455-62-7/Butanoic acid, 2-[3-[[3-(4-chlorobenzoyl)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl]phenoxy]-, (2R)-